| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 137219-37-5 | Didemnin A,N-[1-(1,2-dioxopropyl)-L-prolyl]-; 15H-Pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosine,cyclic peptide deriv.; Aplidin; Aplidine; Dehydrodidemnin B; Plitidepsin | ![]() | C57H87N7O15 | 详情 | 供应商 | |
| 77327-05-0 | Didemnin B (9CI); Didemnin A,N-[1-(2-hydroxy-1-oxopropyl)-L-prolyl]-, (S)-; 15H-Pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosine, cyclic peptidederiv.; L-Tyrosine,(2S)-2-hydroxypropanoyl-L-prolyl-N-methyl-D-leucyl-L-threonyl-(3S,4R,5S)-4-amino-3-hydroxy-5-methylheptanoyl-(2S,4S)-4-hydroxy-2,5-dimethyl-3-oxohexanoyl-L-leucyl-L-prolyl-N,O-dimethyl-,(9® 4)-lactone; NSC 325319; NSC333841 | ![]() | C57H89N7O15 | 详情 | 供应商 | |
| 77327-04-9 | Didemnin A (9CI); 15H-Pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosine,cyclic peptide deriv.; L-Tyrosine, N-[1-[N-[4-[[3-hydroxy-5-methyl-4-[[N-(N-methyl-D-leucyl)-L-threonyl]amino]-1-oxoheptyl]oxy]-2,5-dimethyl-1,3-dioxohexyl]-L-leucyl]-L-prolyl]-N,O-dimethyl-,j-lactone,[3S-[1(2R*,4R*),3R*,4S*,5R*]]-; NSC 351910; [3S-[1(2R*,4R*),3R*,4S*,5R*]]-N-[1-[N-[4-[[3-Hydroxy-5-methyl-4-[[N-(N-methyl-D-leucyl)-L-threonyl]amino]-1-oxoheptyl]oxy]-2,5-dimethyl-1,3-dioxohexyl]-L-leucyl]-L-prolyl]-N,O-dimethyl-L-tyrosinej-lactone | ![]() | C49H78N6O12 | 详情 | 供应商 | |
| 153229-20-0 | Ergosta-7,22,25-triene-3,5,6-triol,(3b,5a,6b,22E,24R)- (9CI); biemnasterol | ![]() | C28H44O3 | 详情 | 供应商 | |
| 72298-61-4 | Decanamide,N-(3-nitrophenyl)-; DEMNA; DECANOYL M-NITROANILINE; N-(3-NITROPHENYL)-DECANAMIDE | ![]() | C16H24N2O3 | 详情 | 供应商 | |
| 161897-96-7 | Heptacosanamide,N-[2-hydroxy-1-(hydroxymethyl)-3-pentadecenyl]- (9CI); Biemnamide | ![]() | C43H85NO3 | 详情 | 供应商 | |
| 117710-03-9 | Nordidemnin B (9CI); Didemnin A,N-[1-(2-hydroxy-1-oxopropyl)-L-prolyl]-3-[(3S,4R)-3-hydroxy-5-methyl-4-aminohexanoicacid]-, (S)-; 15H-Pyrrolo[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotricosine,cyclic peptide deriv.; L-Tyrosine,(2S)-2-hydroxypropanoyl-L-prolyl-N-methyl-D-leucyl-L-threonyl-(3S,4R)-4-amino-3-hydroxy-5-methylhexanoyl-(2S,4S)-4-hydroxy-2,5-dimethyl-3-oxohexanoyl-L-leucyl-L-prolyl-N,O-dimethyl-,(9® 4)-lactone | ![]() | C56H87N7O15 | 详情 | 供应商 | |
| 119202-56-1 | Poly(oxy-1,2-ethanediyl),a-[2-(2-aminomethylethoxy)methylethyl]-w-(4-nonylphenoxy)- (9CI); JeffamineMNPA; Jeffamine MNPA 300; Jeffamine MNPA 510; Jeffamine MNPA 750 | ![]() | (C2H4O)nC21H37NO2 | 详情 | 供应商 | |
| 219828-98-5 | 1H-Pyrrole-2,5-dione,3-(1H-indol-3-yl)-4-(1-methyl-1H-imidazol-4-yl)-; DidemnimideE | ![]() | C16H12N4O2 | 详情 | 供应商 | |
| 186144-28-5 | 1H-Pyrrole-2,5-dione,3-(6-bromo-1H-indol-3-yl)-4-(1-methyl-1H-imidazol-5-yl)-; DidemnimideD | ![]() | C16H11BrN4O2 | 详情 | 供应商 | |
| 186144-21-8 | 1H-Pyrrole-2,5-dione,3-(1H-indol-3-yl)-4-(1-methyl-1H-imidazol-5-yl)-; DidemnimideC; RAB 006 | ![]() | C16H12N4O2 | 详情 | 供应商 | |
| 142808-51-3 | 2-Quinolinecarboxylicacid, 5-(3,4-dihydroxybenzoyl)-4,8-dihydroxy-; Trididemnicacid B | ![]() | C17H11NO7 | 详情 | 供应商 | |
| 142808-50-2 | 2-Quinolinecarboxylicacid, 4,8-dihydroxy-5-(4-hydroxybenzoyl)-; Trididemnicacid A | ![]() | C17H11NO6 | 详情 | 供应商 | |
| 168434-23-9 | 9H-Pyrido[3,4-b]indole,7-bromo-9-[[5-(methylsulfinyl)-1H-imidazol-4-yl]methyl]-; DidemnolineC | ![]() | C16H13BrN4OS | 详情 | 供应商 | |
| 168434-24-0 | 9H-Pyrido[3,4-b]indole,9-[[5-(methylthio)-1H-imidazol-4-yl]methyl]-; DidemnolineB | ![]() | C16H14N4S | 详情 | 供应商 | |
| 168434-25-1 | 9H-Pyrido[3,4-b]indole,9-[[5-(methylsulfinyl)-1H-imidazol-4-yl]methyl]-; DidemnolineD | ![]() | C16H14N4OS | 详情 | 供应商 | |
| 168434-22-8 | 9H-Pyrido[3,4-b]indole,7-bromo-9-[[5-(methylthio)-1H-imidazol-4-yl]methyl]-; DidemnolineA | ![]() | C16H13BrN4S | 详情 | 供应商 | |
| 99120-49-7 | 人胰高血糖素样肽2; 人胰高血糖素样肽2; HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP; HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP-ARG; HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP-ARG: HADGSFSDEMNTILDNLAARDFINWLINTKITDR | GLP-2 (HUMAN); HADGSFSDEMNTILDNLAARDFINWLIQTKITDR; H-HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP-ARG-OH; H-HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP-OH; HIS-ALA-ASP-GLY-SER-PHE-SER-ASP-GLU-MET-ASN-THR-ILE-LEU-ASP-ASN-LEU-ALA-ALA-ARG-ASP-PHE-ILE-ASN-TRP-LEU-ILE-GLN-THR-LYS-ILE-THR-ASP; GLUCAGON-LIKE PEPTIDE-2; GLUCAGON-LIKE PEPTIDE 2 ARG (HUMAN); GLUCAGON-LIKE PEPTIDE 2 (HUMAN); GLUCAGON-LIKE PEPTIDE II HUMAN | 无 | C171H266N48O56S1 | 详情 | 供应商 |